﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Hamadan University of Medical Sciences</PublisherName>
      <JournalTitle>Avicenna Journal of Medical Biochemistry</JournalTitle>
      <Issn>2345-4113</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2025</Year>
        <Month>10</Month>
        <DAY>31</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>The Investigation of Plasma Micro RNAs as Noninvasive Biomarkers for the Prediction of In-Stent Restenosis</ArticleTitle>
    <FirstPage>42</FirstPage>
    <LastPage>50</LastPage>
    <ELocationID EIdType="doi">10.34172/ajmb.2619</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Azadeh</FirstName>
        <LastName>Mozayanimonfared</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-1174-4518</Identifier>
      </Author>
      <Author>
        <FirstName>Behshad</FirstName>
        <LastName>Naghshtabrizi</LastName>
      </Author>
      <Author>
        <FirstName>Hanieh</FirstName>
        <LastName>Naddaf</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-1080-047X</Identifier>
      </Author>
      <Author>
        <FirstName>Farzad</FirstName>
        <LastName>Emami</LastName>
      </Author>
      <Author>
        <FirstName>Amirhossein</FirstName>
        <LastName>Yazdi</LastName>
      </Author>
      <Author>
        <FirstName>Kianoosh</FirstName>
        <LastName>Hosseini</LastName>
      </Author>
      <Author>
        <FirstName>Saeid</FirstName>
        <LastName>Afshar</LastName>
      </Author>
      <Author>
        <FirstName>Sara</FirstName>
        <LastName>Zebarjadi</LastName>
      </Author>
      <Author>
        <FirstName>Leila</FirstName>
        <LastName>Norozei</LastName>
      </Author>
      <Author>
        <FirstName>Nima</FirstName>
        <LastName>Naghshtabrizi</LastName>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Esfahani</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-5718-7126</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/ajmb.2619</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>05</Month>
        <Day>30</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>08</Month>
        <Day>04</Day>
      </PubDate>
    </History>
    <Abstract>Background: In-stent restenosis (ISR) is a detrimental complication that takes place following coronary stenting. There is strong evidence that micro ribonucleic acids (miRNAs) are involved in inflammation and neointimal formation. Objectives: The current study aimed to explore the role of some circulating miRNAs in restenosis patients. Methods: A total of 62 patients were enrolled in this study. According to angiography, the patients were grouped into restenosis and non-restenosis groups. The plasma levels of miR-21, miR-126, miR-143/miR-145, and miR-222 were analyzed with quantitative real-time polymerase chain reaction. Results: The plasma expression level of miR-21 (P=0.003) was significantly higher compared to the control group. In addition, the plasma levels of miR-126 (P=0.004), miR-143 (P=0.003), and miR-145 (P=0.008) were considerably lower in the ISR group compared with the control group. In the ISR group, the plasma level of miR-222 was increased, but this increase was not significant (P=0.08). Conclusion: The results revealed differential changes in the plasma level of miRNAs. Some miRNAs may have critical functions in restenosis pathogenesis, and others may have protective effects. Overall, evidence suggests a predictive role for miRs following interventional therapy.  </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Restenosis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Inflammation</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">miR-21</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">miR-126</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">miR-143</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">miR-145</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>